Can hydrochlorothiazide cause itching?

Can Hydrochlorothiazide Cause Itching?

Yes, hydrochlorothiazide (HCTZ) can cause itching (pruritus), which may occur as part of various hypersensitivity reactions including photosensitivity, urticaria, rash, and purpura. 1

Mechanism and Clinical Presentation

HCTZ-induced itching occurs through multiple mechanisms:

• Photosensitivity reactions are particularly common with thiazide diuretics, affecting patients exposed to ultraviolet radiation and presenting as burning, tingling sensations with associated erythema in sun-exposed areas 2
• Direct hypersensitivity reactions including urticaria, rash, and purpura are documented adverse effects that frequently involve pruritus 1
• Photosensitive eruptions can manifest as exaggerated sunburn reactions, dermatitis, or lichenoid eruptions, all typically accompanied by itching 2

FDA-Documented Adverse Reactions

The FDA drug label explicitly lists the following pruritus-related adverse reactions for HCTZ 1:

• Hypersensitivity reactions: urticaria, rash, purpura
• Photosensitivity: a recognized adverse effect
• Severe cutaneous reactions: erythema multiforme, Stevens-Johnson syndrome, exfoliative dermatitis including toxic epidermal necrolysis (all associated with severe itching)

Clinical Evidence

Multiple case reports and studies document HCTZ-induced dermatological reactions with pruritus:

• Photosensitivity dermatitis is well-documented, with eczematous lesions in photodistributed patterns being the most common presentation 3
• Exfoliative rash with progressive symptoms has been reported following HCTZ initiation 4
• Acute generalized exanthematous pustulosis (AGEP) has been documented as a rare but severe reaction to HCTZ 5
• Severe allergic reactions mimicking septic shock have occurred, with symptoms developing within hours of HCTZ administration 6

Risk Factors and Sun Exposure

Patients taking HCTZ face increased risk when exposed to ultraviolet radiation 2:

• Sun exposure timing: Risk is highest around midday and in areas with high sun exposure
• Reflective surfaces: Water, sand, and snow increase radiation exposure
• Geographic factors: Altitude and proximity to equator affect ultraviolet intensity

Management Recommendations

If HCTZ-induced itching is suspected:

1. Immediately discontinue HCTZ and switch to a non-thiazide antihypertensive class 7

2. Assess severity of cutaneous involvement and presence of systemic symptoms 1

3. Implement sun protection if photosensitivity is present: seek shade, wear protective clothing, use broad-spectrum sunscreen (SPF ≥30) 2

4. Symptomatic treatment for mild-to-moderate pruritus 8:

   • Topical moderate-to-high potency corticosteroids (mometasone furoate 0.1% or betamethasone valerate 0.1%)
   • Oral antihistamines: second-generation (loratadine 10 mg daily) for daytime; first-generation (diphenhydramine 25-50 mg or hydroxyzine 25-50 mg) for nighttime sedation
   • Topical menthol 0.5% or lotions containing urea or polidocanol

5. For severe or refractory cases 8:

   • GABA agonists: pregabalin (25-150 mg daily) or gabapentin (900-3600 mg daily) as second-line therapy
   • Systemic corticosteroids (0.5-2 mg/kg daily) for temporary relief of severe pruritus

Important Caveats

• Cross-reactivity concerns: While HCTZ contains a sulfonamide moiety, there is minimal concern for cross-reactivity with sulfonamide antibiotics due to structural differences 9
• Sulfa allergy history: Patients with documented sulfonamide antibiotic allergies may have predisposition to drug allergies generally, though the mechanism differs from true cross-sensitivity 6
• Alternative diuretics: Loop diuretics (furosemide, bumetanide) or other antihypertensive classes should be substituted rather than other thiazide diuretics, which share similar photosensitivity risk 2, 9